Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials

INTRODUCTION: Ovarian cancer is the most lethal gynecologic malignancy. Although treatment with hyperthermic intraperitoneal chemotherapy (HIPEC) has shown promising results, its role remains elusive. The aim of this study was to assess the comprehensive randomized evidence for the use versus non-us...

Descripción completa

Detalles Bibliográficos
Autores principales: Filis, P., Mauri, D., Markozannes, G., Tolia, M., Filis, N., Tsilidis, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588894/
https://www.ncbi.nlm.nih.gov/pubmed/36116421
http://dx.doi.org/10.1016/j.esmoop.2022.100586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588894/
https://www.ncbi.nlm.nih.gov/pubmed/36116421
http://dx.doi.org/10.1016/j.esmoop.2022.100586

Ejemplares similares